GRA_Logo

 + Home + About Us + Contact Us
 
+ Drug Delivery   + Monitoring & Diagnostics   + Healthcare    + Therapeutics    + Wound Care
 
Iontophoresis Drug Delivery
Devices, Drugs and Therapeutic Prospects


About This Report

Price: US $2,850

Publication: May 2011

Product Code: NTR222P




To expand the limits of transdermal drug delivery, developers are employing energy sources such as ultrasound, heat and electrical current to affect active transport through the skin. These techniques can increase the upper molecular size limit dramatically, opening up a host of opportunities for iontophoretic delivery. Iontophoresis devices with ease-of-use features have the potential to address the needs of an aging population for user-friendly delivery and are positioned to make a significant impact in selected therapeutic areas. This report includes analysis of iontophoretic transdermal technologies, market and regulatory factors, product evaluations, and profiles of leading sector participants.
Highlights

· Analyzes and evaluates iontophoresis devices for drug delivery and assesses risks and  market potential

· Analyzes iontophoresis device designs, technologies and market development issues

· Provides detailed description of iontophoresis market segments, market demographics and business strategies

· Provides market data and forecasts to 2015

· Profiles iontophoresis device   manufacturers, their product development activities and strategies
Summary of Contents
Executive Summary

Market Dynamics

The Trend toward Self-Care
Shifting Demographics
Demand Drivers
Competitive Landscape
Risk Factors

Iontophoresis Device Design Factors

Human Engineering/Ease of Use
Device Adhesion
Dosing and Rate Factors
Electrode Design
Power Requirements & Battery Technology

Key Iontophoresis Therapeutic Application Segment Analysis

Anesthesia
Dermatology
Neurology
Pain Management
Physical Medicine
Women’s Health

Iontophoresis Product Assessments and Forecasts

Disposable Single-use products
Discrete Controller Devices
Reusable Devices
Programmable Systems

Market Factors

FDA/CDRH Requirements
Combination Product Regulatory Issues
Patient Compliance Factors
Healthcare Economics
Rx-to-OTC Switching
Alliances and Partnerships
Contract Design and Manufacturing

Profiles of Market Participants




 

 

Recent Research

Prefilled Syringes to 2016

Drug Self-Administration Markets to 2016

Therapeutic Proteins to 2016


Events

American Association for Clinical Chemistry (July 2012)

World Congress on Glucose Monitoring and Insulin Delivery (April 2012)

 
     
 
Greystone Research Associates
98 Route 101A, Suite 17
Amherst, NH 03031 USA

Phone: 603-595-4340/ Fax: 603-218-7020
Copyright 2011 ·  Greystone Research Associates  ·  All Rights Reserved · Conditions of Use  ·  Career